Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Biomaterials. 2011 Oct;32(30):7662-70. doi: 10.1016/j.biomaterials.2011.01.043. Epub 2011 Jul 19.
Nano-structured calcium phosphate (NanoCaP) particles have been proven to be a powerful means of non-viral gene delivery. In order to better understand the mechanisms through which NanoCaPs-mediated mammalian cell transfection is achieved, we have sought to define the intracellular trafficking pathways involved in the cellular uptake and intracellular processing of these particles. Previous work has indicated that NanoCaP-DNA complexes are most likely internalized via endocytosis, however the subsequent pathways involved have not been determined. Through the use of specific inhibitors, we show that endocytosis of NanoCaP particles is both clathrin- and caveolae-dependent, and suggest that the caveolaer mechanism is the major contributor. We demonstrate colocalization of NanoCaP-pDNA complexes with known markers of both clathrin-coated and caveolar vesicles. Furthermore, through the use of quantitative flow cytometry, we present the first work in which the percent internalization of CaP-DNA complexes into cells is quantified. The overall goal of this research is to foster the continued improvement of NanoCaP-based gene delivery strategies.
纳米结构磷酸钙 (NanoCaP) 颗粒已被证明是一种强大的非病毒基因传递手段。为了更好地理解 NanoCaP 介导的哺乳动物细胞转染的机制,我们试图确定涉及这些颗粒的细胞摄取和细胞内加工的细胞内运输途径。先前的工作表明,NanoCaP-DNA 复合物很可能通过内吞作用被内化,但是尚未确定随后涉及的途径。通过使用特异性抑制剂,我们表明 NanoCaP 颗粒的内吞作用既依赖于网格蛋白又依赖于小窝蛋白,并且表明小窝蛋白机制是主要贡献者。我们证明了 NanoCaP-pDNA 复合物与已知的网格蛋白包被囊泡和小窝囊泡标记物的共定位。此外,通过使用定量流式细胞术,我们首次定量了 CaP-DNA 复合物进入细胞的内化百分比。这项研究的总体目标是促进基于 NanoCaP 的基因传递策略的持续改进。